Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review

Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NF-kappaB signaling pathways

(2010) Sahdeo Prasad et al.   CANCER BIOLOGY & THERAPY

Telomerase as an emerging target to fight cancer — Opportunities and challenges for nanomedicine

(2010) C. Philippi et al.   JOURNAL OF CONTROLLED RELEASE

Transcriptome and Functional Analysis of the Eukaryotic-Type Serine/Threonine Kinase PknB in Staphylococcus aureus

(2009) S. Donat et al.   JOURNAL OF BACTERIOLOGY

Cancer stem cells as targets for cancer therapy: selected cancers as examples

(2008) Sabine Hombach-Klonisch et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK

(2008) Dong-Oh Moon et al.   BIOCHEMICAL PHARMACOLOGY

Cytoskeletal toxicity of pectenotoxins in hepatic cells

(2008) B Espiña et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pectenotoxin-2 abolishes constitutively activated NF-κB, leading to suppression of NF-κB related gene products and potentiation of apoptosis

(2008) Mun-Ock Kim et al.   CANCER LETTERS

Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation

(2008) Mun-Ock Kim et al.   FEBS LETTERS